Data on Abbott Labs' (ABT) minimally invasive MitraClip for closing up leaky heart valves...

|About: Abbott Laboratories (ABT)|By:, SA News Editor

Data on Abbott Labs' (ABT) minimally invasive MitraClip for closing up leaky heart valves doesn't prove the safety or effectiveness of the device, FDA staff say ahead of a meeting of an advisory panel on Wednesday. Another trial may provide better data that could support authorization, but the study isn't due to be completed until mid-2019.